Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

40 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Somatic mutations of thymic epithelial tumors with myasthenia gravis.
Pardini E, Cucchiara F, Palumbo S, Tarrini G, Di Vita A, Coppedè F, Nicolì V, Guida M, Maestri M, Ricciardi R, Aprile V, Ambrogi MC, Barachini S, Lucchi M, Petrini I. Pardini E, et al. Among authors: cucchiara f. Front Oncol. 2023 Aug 21;13:1224491. doi: 10.3389/fonc.2023.1224491. eCollection 2023. Front Oncol. 2023. PMID: 37671056 Free PMC article.
Precision Medicine in Lymphoma by Innovative Instrumental Platforms.
Di Paolo A, Arrigoni E, Luci G, Cucchiara F, Danesi R, Galimberti S. Di Paolo A, et al. Among authors: cucchiara f. Front Oncol. 2019 Dec 17;9:1417. doi: 10.3389/fonc.2019.01417. eCollection 2019. Front Oncol. 2019. PMID: 31921674 Free PMC article. Review.
erbB in NSCLC as a molecular target: current evidences and future directions.
Del Re M, Cucchiara F, Petrini I, Fogli S, Passaro A, Crucitta S, Attili I, De Marinis F, Chella A, Danesi R. Del Re M, et al. Among authors: cucchiara f. ESMO Open. 2020 Aug;5(4):e000724. doi: 10.1136/esmoopen-2020-000724. ESMO Open. 2020. PMID: 32820012 Free PMC article. Review.
A multiparametric approach to improve the prediction of response to immunotherapy in patients with metastatic NSCLC.
Del Re M, Cucchiara F, Rofi E, Fontanelli L, Petrini I, Gri N, Pasquini G, Rizzo M, Gabelloni M, Belluomini L, Crucitta S, Ciampi R, Frassoldati A, Neri E, Porta C, Danesi R. Del Re M, et al. Among authors: cucchiara f. Cancer Immunol Immunother. 2021 Jun;70(6):1667-1678. doi: 10.1007/s00262-020-02810-6. Epub 2020 Dec 14. Cancer Immunol Immunother. 2021. PMID: 33315149 Free PMC article.
Multiple Resistance Mechanisms to Tyrosine Kinase Inhibitors in EGFR Mutated Lung Adenocarcinoma: A Case Report Harboring EGFR Mutations, MET Amplification, and Squamous Cell Transformation.
Bruno R, Del Re M, Cucchiara F, Petrini I, Alì G, Crucitta S, Proietti A, Valleggi S, Chella A, Danesi R, Fontanini G. Bruno R, et al. Among authors: cucchiara f. Front Oncol. 2021 Jun 11;11:674604. doi: 10.3389/fonc.2021.674604. eCollection 2021. Front Oncol. 2021. PMID: 34178662 Free PMC article.
Treatment-driven tumour heterogeneity and drug resistance: Lessons from solid tumours.
Crucitta S, Cucchiara F, Mathijssen R, Mateo J, Jager A, Joosse A, Passaro A, Attili I, Petrini I, van Schaik R, Danesi R, Del Re M. Crucitta S, et al. Among authors: cucchiara f. Cancer Treat Rev. 2022 Mar;104:102340. doi: 10.1016/j.ctrv.2022.102340. Epub 2022 Feb 1. Cancer Treat Rev. 2022. PMID: 35151155 Review.
Comparison of digital PCR systems for the analysis of liquid biopsy samples of patients affected by lung and colorectal cancer.
Crucitta S, Ruglioni M, Novi C, Manganiello M, Arici R, Petrini I, Pardini E, Cucchiara F, Marmorino F, Cremolini C, Fogli S, Danesi R, Del Re M. Crucitta S, et al. Among authors: cucchiara f. Clin Chim Acta. 2023 Feb 15;541:117239. doi: 10.1016/j.cca.2023.117239. Epub 2023 Feb 2. Clin Chim Acta. 2023. PMID: 36736684 Free article.
40 results